Lv41
430 积分 2025-04-16 加入
PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets
5小时前
待确认
Structural and mechanistic insights into peptidylarginine deiminase (PAD2/PAD4) mediated citrullination and therapeutic targeting: A review
5小时前
已完结
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study
9天前
已完结
Epidemiological Profiles of Hepatitis B Virus Genotypes Among 1–69-year-olds in the Mainland of China
10天前
已完结
Newcomer anti-IL-33 makes strides in COPD
12天前
已完结
Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access program
14天前
已关闭
Epidemiological distribution of hepatitis B virus genotypes in 1-29-year-olds in the mainland of China
21天前
已完结
ABS0223 PROFILING OF MT-3534, A HUMANIZED MONOCLONAL ANTIBODY TARGETING PAD4, AS A CANDIDATE DRUG FOR THE TREATMENT OF RA
26天前
已关闭
The Impact of Hepatitis B Surface Antigen Reduction via Small Interfering RNA Treatment on Natural and Vaccine (BRII-179)-Induced Hepatitis B Virus-Specific Humoral and Cellular Immune Responses
1个月前
已完结
Mechanism of interferon alpha therapy for chronic hepatitis B and potential approaches to improve its therapeutic efficacy
1个月前
已完结
皖公网安备34019202002308
